Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Lysocin E, a 37-membered natural depsipeptide, induces rapid bacteriolysis in methicillin-resistant Staphylococcus aureus via a unique menaquinone-dependent mechanism, presenting a promising therapeutic lead. Despite the great medical importance, exploring the potential utility of its derivatives as new platform structures for antibiotic development has remained a significant challenge. Here, we report a high-throughput strategy that enabled the preparation of thousands of analogues of lysocin E and large-scale structure-activity relationship analyses. We integrate 26-step total synthesis of 2401 cyclic peptides, tandem mass spectrometry-sequencing, and two microscale activity assays to identify 23 candidate compounds. Re-synthesis of these candidates shows that 11 of them (A1-A11) exhibit antimicrobial activity superior or comparable to that of lysocin E, and that lysocin E and A1-A11 share L-Leu-6 and L-Ile-11. Therefore, the present strategy allows us to efficiently decipher biologically crucial residues and identify potentially useful agents for the treatment of infectious diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611794PMC
http://dx.doi.org/10.1038/s41467-019-10754-4DOI Listing

Publication Analysis

Top Keywords

high-throughput strategy
8
lysocin lysocin
8
lysocin
5
development high-throughput
4
strategy discovery
4
discovery potent
4
potent analogues
4
analogues antibiotic
4
antibiotic lysocin
4
lysocin 37-membered
4

Similar Publications

Ultra-high field strength electroporation enables efficient DNA transformation and genome editing in nontuberculous mycobacteria.

Microbiol Spectr

September 2025

Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Efficient DNA delivery is essential for genetic manipulation of mycobacteria and for dissecting their physiology, pathogenesis, and drug resistance. Although electroporation enables transformation efficiencies exceeding 10⁵ CFU per µg DNA in and , it remains highly inefficient in many nontuberculous mycobacteria (NTM), including . Here, we discovered that NTM such as exhibit exceptional tolerance to ultra-high electric field strengths and that hypertonic preconditioning partially protects cells from electroporation-induced damage.

View Article and Find Full Text PDF

Introduction: Feline herpesvirus type 1 (FHV-1) is a primary pathogen causing feline upper respiratory tract diseases (FURTD), but its impact on the upper respiratory tract microbiota remains unclear. This study aimed to evaluate the impact of FHV-1 infection on the upper respiratory tract microbiota by comparing the microbial composition between FHV-1-positive group with FHV-1-negative group.

Methods: The microbial diversity in the upper respiratory tract of FHV-1-positive cats ( = 8) were analyzed using 16S rRNA high-throughput sequencing, and then this diversity was compared with that in healthy FHV-1-negative controls ( = 4).

View Article and Find Full Text PDF

Identification and Validation of Inverse Agonists for Nuclear Receptor Subfamily 4 Group A Member 2.

ACS Omega

September 2025

Key Laboratory of Liaoning Province for Research on the Pathogenic Mechanisms of Neurological Diseases, The First Affiliated Hospital, Dalian Medical University, 116021 Dalian, China.

Former studies indicate that nuclear receptor subfamily 4 group A member 2 (Nurr1, NR4A2), a transcription factor, is regarded as a potential therapeutic target for central nervous system diseases, and many studies have focused on the development and optimization of agonists of Nurr1. Recent studies have shown that Nurr1 is upregulated in many other diseases. However, there is still a lack of effective inverse Nurr1 agonists as a therapeutic strategy or as pharmacological tools to counteract the receptor's inherent activity.

View Article and Find Full Text PDF

Motivation: Advances in high-throughput technologies have shifted the focus from bulk to single cell or spatial transcriptomic and proteomic analysis of tissues and cell cultures. The resulting increase in gene and/or protein lists leads to the subsequent growth of up- and downregulated pathways lists. This trend creates the need for pathway-network based integration strategies that allow quick exploration of shared and distinct mechanisms across datasets.

View Article and Find Full Text PDF

Umbilical cord blood-derived exosomes deliver miR-182-5p to Therapeutically target the MYD88/NF-κB signaling pathway in rat peri-implantitis.

Mater Today Bio

October 2025

Department of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.

Peri-implantitis (PI) is a major cause of implant restoration failure, necessitating therapeutic strategies that integrate bone regeneration and anti-inflammatory effects. Despite advances in treatment, no existing agents simultaneously address both objectives. Exosomes (Exos), as key mediators of intercellular communication, have demonstrated dual anti-inflammatory and osteogenic capacities through microRNA (miRNA) delivery; however, their potential in PI therapy remains unexplored.

View Article and Find Full Text PDF